Danxiao Suanyi Shanli Zhi Huanshijiaonang (单硝酸异山梨酯缓释胶囊)单硝酸异山梨酯缓释胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 珠海润都制药股份有限公司Chinese legal name: 珠海润都制药股份有限公司
主要成分Active Ingredients
- 单硝酸异山梨酯Danxiao Suanyi Shanli Zhi
药物知识说明
单硝酸异山梨酯是一种在国家药监局注册认定的药品。该药品含有单硝酸异山梨酯-78b15725等成分。
该药品关联的活性成分包括：单硝酸异山梨酯Danxiao Suanyi Shanli Zhi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：珠海润都制药股份有限公司Chinese legal name: 珠海润都制药股份有限公司。
您可以探索含有相同成分的其他药品：单硝酸异山梨酯-78b15725成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 单硝酸异山梨酯缓释胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 单硝酸异山梨酯Danxiao Suanyi Shanli Zhi.
Manufacturers recorded for this product: 珠海润都制药股份有限公司Chinese legal name: 珠海润都制药股份有限公司.
Explore other medicines containing the same ingredient: 单硝酸异山梨酯 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 单硝酸异山梨酯缓释胶囊Recorded Chinese name: 单硝酸异山梨酯缓释胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 50mg*20粒50 mg × 20 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 珠海润都制药股份有限公司Chinese legal name: 珠海润都制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20073914
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20073914
Manufacturer
Chinese legal name: 珠海润都制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
50 mg × 20 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字H20073914
生产企业
珠海润都制药股份有限公司(国产)
适应症
1.冠心病的长期治疗。 2.心绞痛的预防。 3.心肌梗死后持续心绞痛的治疗。 4.与洋地黄和/或利尿剂联合应用，治疗慢性充血性心力衰竭。
用法用量
口服：一次40mg，每日一次，早饭后服。
不良反应
用药初期可能会出现硝酸酯引起的血管扩张性头痛，通常连续服用数日后，症状可消失。还可能出现面部潮红、眩晕、直立性低血压和反射性心动过速。偶见血压明显降低、心动过缓、心绞痛加重和晕厥。
禁忌
急性循环衰竭（休克、循环性虚脱）；严重低血压（收缩压<90 mmHg）；急性心肌梗死伴低充盈压（除非在有持续血流动力学监测的条件下）；肥厚梗阻型心肌病；缩窄性心包炎或心包填塞；严重贫血；青光眼；颅内压增高；对硝基化合物过敏者。
注意事项
低充盈压的急性心肌梗死患者，应避免收缩压低于90mmHg。主动脉和/或二尖瓣狭窄、体位性低血压及肾功能不全者慎用。
贮藏
遮光、密封保存。
规格
50mg*20粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.